BioSpace News Archive

Scopus BioPharma Inc. today announced the release of preclinical data being presented at the 17th Annual Meeting of the Oligonucleotide Therapeutics Society.

Evoke Pharma® (NASDAQ: EVOK), , and EVERSANA™, today announced that PM360, named both companies as the Sales Aid Silver Award Winner for GIMOTI® under the Trailblazer Initiative Awards during PM360’s annual awards ceremony on September 23, 2021.

Wave Life Sciences Ltd. today announced the initiation of dosing in a Phase 1b/2a clinical trial evaluating investigational WVE-N531 as a treatment for boys with Duchenne muscular dystrophy (DMD)

Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that company management will participate in, and present at, the Reuters Events’ Cell & Gene Therapy USA 2021 event, which is taking place virtually on September 28 and 29, 2021.

Neurelis, Inc. announced today that it is presenting two posters at the 50th Annual Meeting of the Child Neurology Society in Boston from September 29 through October 2.

Freenome, a privately-held biotech company, presented new research today at the American Association of Cancer Research (AACR) Special Conference on Pancreatic Cancer.

Healthtech company Huma and the life sciences company Bayer will use machine learning to try to improve diagnosis for certain types of lung cancer, by more precise readings of CT (Computed Tomography) scans.

The AccumTM technology platform was initially designed to enhance the accumulation of specific proteins, antibodies (ADCs) or antigen in target cells. Studies conducted by Defence revealed a strong therapeutic function for AccumTM when delivered on its own.

Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life-threatening conditions, announced preliminary top line results from ongoing biomarker analysis from the Company’s Phase 2b trial of Lomecel-B investigational cell therapy in Aging Frailty subjects.

Northwest Specialty Hospital and Axis Spine Center have become the first specialty hospital in the U.S. to provide personalized spine surgery with aprevo® patient-specific surgical plans and spine fusion devices.